Neurocrine Biosciences (NBIX) | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Neurocrine Biosciences (NBIX)

An SI Board Since July 1996

Posts	SubjectMarks	Bans	Symbol
1834	74	0	NBIX

Emcee: Billy Dunn	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
1709	Sounds like a shameless pumper to me. ido	idos	-	1/29/2007
1708	I received the most pumped up/bizarre? feed today in my mailbox about NBIX..I do	zeta1961	-	1/28/2007
1707	fwiw, I did sell half my trading position today. will keep the other half as th	mopgcw	-	1/24/2007
1706	I took my loss (on DOVP) and most of my gains on SEPR and have not done in-depth	Robohogs	-	1/23/2007
1705	The points and concerns about generic Ambien coming to market in a few months se	mcbio	-	1/23/2007
1704	UBS raised target to $14 and kept recently raised Hold. Was $8.50 and Sell or R	Robohogs	-	1/23/2007
1703	As you say, it is in fact a reiteration though it's not labelled as such.	tom pope	-	1/23/2007
1702	Quite the case of dueling analysts. Merrill's note is apparently not a reit	tuck	-	1/23/2007
1701	Me, too. I shorted at $13.50. I consider it a long term sell & hold, and ma	tuck	-	1/23/2007
1700	Merrill unimpressed: Indiplon potential still small despite accelerated filing	tom pope	-	1/23/2007
1699	If the short-acting Indiplon makes it to market, will anyone care?	DewDiligence_on_SI	-	1/22/2007
1698	either nbix grip on the process or changes at the FDA or BOTH??	mopgcw	-	1/22/2007
1697	<i> Are any current holders tempted to sell this news? </i> yes, bu	mopgcw	-	1/22/2007
1696	I was referring to the company's record in "guiding" investors alo	Icebrg	-	1/22/2007
1695	Whose confusion are you talking about, Erik? It's nice to be able to accele	tuck	-	1/22/2007
1694	Neurocrine Announces Plans to Resubmit NDA for Indiplon Capsules in Q2 2007 Mond	Icebrg	-	1/22/2007
1693	fwiw: Neurocrine Upped To Overweight From Equalweight By Lehman & Neurocrine	mopgcw	-	1/17/2007
1692	Ambit Biosciences Appoints Wendell Wierenga, Ph.D., as Executive Vice President	Icebrg	-	1/9/2007
1691	Neurocrine Biosciences Announces Positive Results From Second Phase II Study Wit	Icebrg	-	1/8/2007
1690	i guess i would be anxious if i had IBS, so the dual track indications make sens	mopgcw	-	12/20/2006
1689	>>Neurocrine Biosciences Announces Initiation of Phase II Clinical Trials	tuck	-	12/20/2006
1688	Thanks for the pointer, Rick..very disappointing..eom	zeta1961	-	12/11/2006
1687	Message 23090430 IL-4 sister program bombs.	scaram(o)uche	-	12/11/2006
1686	Neurocrine Biosciences upgraded to "peer perform" Friday, November 17	Icebrg	-	11/18/2006
1685	citi: Today, Neurocrine reported Q3 2006 earnings, but given Neurocrine’s rece	mopgcw	-	11/14/2006

Go to reply# or date (mm/dd/yy):